CS
EPIX

Credit Suisse’s ESSA Pharma EPIX Stock Holding History

Credit Suisse’s Portfolio EPIX Stock Details EPIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-22,306
Closed -$139K – 4028
2022
Q1 		$139K Buy
22,306
+9,933
+80% +$87.3K ﹤0.01% 3450
2021
Q4 		$176K Sell
12,373
-1,340
-10% -$14.9K ﹤0.01% 4303
2021
Q3 		$110K Buy
13,713
+1,487
+12% +$23.6K ﹤0.01% 4312
2021
Q2 		$348K Buy
+12,226
New +$355K ﹤0.01% 4039

Other funds holding EPIX

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $24.2B AUM 26.83% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return